Targeting residual visual pathways to develop effective rehabilitation for patients with hemianopia (360G-Wellcome-224655_Z_21_Z)

£820,936

Hemianopia is common following acquired brain injury, and is estimated to affect over 230,000 people living in the UK. Despite its high prevalence and well-described impact on society, it is a neglected clinical problem with no treatments to recover vision. My research shows that patients with hemianopia can show residual vision in their blind field, a phenomenon called 'blindsight'. Patterns of blindsight and one's capacity for visual retraining appear to vary according to the presence of preserved 'secondary' visual pathways. Where pathways remain intact, they represent an important potential target for rehabilitation. I will use cutting-edge neuroimaging techniques in patients and healthy controls to build a normative connectivity atlas of the central visual pathways. I will quantify the relationship between secondary visual pathway integrity and function in patients and controls, to learn how to optimally drive their response. I will use results to develop a novel visual-training protocol targeting the ventral visual stream, and test whether the integrity of ventral and dorsal visual pathways can predict improvement with visual training protocols targeting those two domains in patients with hemianopia. Understanding the secondary visual pathways will expand neural targets and enhance precision through a customised approach to treat hemianopia.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 820936
Applicant Surname Ajina
Approval Committee Clinical Interview Committee
Award Date 2021-11-16T00:00:00+00:00
Financial Year 2021/22
Grant Programme: Title Clinical Research Career Development Fellowship - Stage 1
Has the grant transferred? No
Internal ID 224655/Z/21/Z
Lead Applicant Dr Sara Ajina
Planned Dates: End Date 2027-06-14T00:00:00+00:00
Planned Dates: Start Date 2022-06-15T00:00:00+00:00
Recipient Org: City London
Recipient Org: Country United Kingdom
Region London
Research conducted at multiple locations? Yes
Sponsor(s) Prof Heidi Johansen-Berg, Dr Franco Pestilli, Prof Catherine Price
Total amount including partnership funding 820936